In this episode of Hardman Talks, Dr Martin Hall, Hardman & Co Life Sciences analyst, talks to Donald Leggatt of London South East. They discuss the attractions of life sciences investments over the long term, and the role of the Hardman & Co Healthcare Index in valuing the sector over time.
The latest edition of the Healthcare Index was published this month (read it here in full here). Martin’s extensive experience means he has data going back to the 1980s and has been running the index for over a decade. 2020 was an exceptional year for life sciences companies, and the index bears this out with an increase of nearly 20%.